Catalys Pacific Fund LP 13D and 13G filings for Mineralys Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:05 pm Purchase | 2025-06-30 | 13G | Mineralys Therapeutics, Inc. MLYS | Catalys Pacific Fund LP | 8,978,954 13.500% | 297,709 (+3.43%) | Filing |
| 2024-11-13 4:09 pm Sale | 2024-09-30 | 13G | Mineralys Therapeutics, Inc. MLYS | Catalys Pacific Fund LP | 8,681,245 17.400% | -528,000 (-5.73%) | Filing |
| 2024-02-13 4:12 pm Purchase | 2023-12-31 | 13G | Mineralys Therapeutics, Inc. MLYS | Catalys Pacific Fund LP | 9,209,245 22.400% | 9,209,245 (New Position) | Filing |